cro.directory
← Compare landing

Altasciences vs Protheragen

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/altasciences/obesityscientific

CategoryAltasciencesProtheragen
Listed sitebothcro
SummaryMid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities.Specialized preclinical CRO focused on obesity research, offering comprehensive animal models, pharmacokinetic/pharmacodynamic studies, bioanalysis, and safety assessment for anti-obesity drug development.
Services
  • Preclinical In Vivo Studies
  • GLP Toxicology
  • Safety Pharmacology
  • In Vitro Pharmacology
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Clinical Trial Services
  • Bioanalysis
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Biostatistics & Statistical Programming
  • Data Management & eClinical
  • Medical Writing
  • Clinical Operations
  • Regulatory Affairs
  • In Vivo PK / PD Studies
  • Preclinical In Vitro Studies
  • Phase IV / Post-Marketing
  • In Vitro ADME / DMPK
  • Formulation Development
  • Stability Testing & Storage
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Safety Pharmacology
  • GLP Toxicology
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • Specialized & Large-Animal Models
  • Target Identification & Validation
  • Medicinal Chemistry
  • Regulatory Affairs
  • Medical Writing
  • Clinical Operations
  • Biostatistics & Statistical Programming
  • Data Management & eClinical
  • Pharmacovigilance & Drug Safety
Modalities
  • Small Molecule
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Small Molecule
  • Gene Therapy
  • Cell Therapy
  • Biologics (Monoclonal Antibodies)
  • Peptide
Indications
  • Cardiovascular
  • Dermatology
  • Gastroenterology
  • Immunology
  • Infectious Disease
  • Metabolic
  • Neurology
  • Oncology
  • Ophthalmology
  • Psychiatry
  • Respiratory
  • Women's Health
  • Metabolic
Locations
  • Headquarters, Montreal, Quebec, Canada
  • Bioanalytical Laboratory, Laval, Quebec, Canada
  • Clinical Site, Montreal, Quebec, Canada
  • Clinical and Research Campus, Overland Park, Kansas, United States
  • Preclinical Testing, Everett, Washington, United States
  • Manufacturing and Analytical Services, Harleysville, Pennsylvania, United States
  • Preclinical Testing, Scranton, Pennsylvania, United States
  • Preclinical Testing, Columbia, Missouri, United States
  • Clinical Pharmacology, Cypress, California, United States
  • Preclinical Testing, Sacramento, California, United States
  • Laval, Laval, Quebec, Canada
  • Overland Park, Overland Park, Kansas, United States
  • Everett, Everett, Washington, United States
  • Harleysville, Harleysville, Pennsylvania, United States
  • Cypress, Cypress, California, United States
  • Scott Township, Scott Township, Pennsylvania, United States
  • Auxvasse, Auxvasse, Missouri, United States
  • Sacramento, Sacramento, California, United States
  • Canada, Canada, Canada
  • United States, United States, United States
  • Canada and U.S. operations
Data not yet provided.
Certifications
  • FDA · Identifier: FDA inspection passed 2001
  • GLP · Identifier: GLP Compliant
  • GMP · Identifier: GMP Manufacturing
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.